Improvement in Health-Related Quality of Life in Patients With Moderate to Severe Crohn's Disease Treated With Risankizumab Versus Ustekinumab in the Phase 3B SEQUENCE Study

Inflammatory Bowel Disease
Do you want to read an article? Please log in or register.